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Abstract
Magnesium lithospermate B (MLB) is one of the major 
active components of Salvia miltiorrhizae. The anti-ox-
idative effects of Salvia miltiorrhizae have been pre-
viously reported. The aim of this study was to inves-
tigate the effect of purified MLB on hepatic fibrosis in 
rats and on the fibrogenic responses in hepatic stellate 
cells (HSCs). Hepatic fibrosis was induced in rats by in-
traperitoneal thioacetamide (TAA) injections over a pe-
riod of 8 or 12 weeks. MLB was orally administered daily 
by gavage tube. Serum AST and ALT levels in TAA + 
MLB group were significantly lower than those in TAA 
only group at week 8. Hepatic fibrosis was significantly 
attenuated in TAA + MLB group than in TAA only group 
at week 8 or 12. Activation of HSCs was also decreased 
in TAA + MLB group as compared to TAA only group. 
Hepatic mRNA expression of α-smooth muscle actin 
(α-SMA), TGF-β1, and collagen α1(I) was significantly 
decreased in TAA + MLB group as compared to TAA 
only group. Incubation with HSCs and MLB (≥100 μM) 
for up to 48 h showed no cytotoxicity. MLB suppressed 
PDGF-induced HSC proliferation. MLB inhibited 
NF-κB transcriptional activation and monocyte che-
motactic protein 1 (MCP-1) production in HSCs. MLB 
strongly suppressed H2O2-induced reactive oxygen 
species (ROS) generation in HSCs, and MLB inhibited 
type I collagen secretion in HSCs. We concluded that 
MLB has potent antifibrotic effect in TAA-treated cir-
rhotic rats, and inhibits fibrogenic responses in HSCs. 
These data suggest that MLB has potential as a novel 
therapy for hepatic fibrosis.
Keywords: liver cirrhosis; Salvia miltiorrhiza; hepatic 
stellate cells; lithospermate B; reactive oxygen spe-
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Introduction
Hepatic fibrosis refers to a wound-healing response 
to various kinds of liver injuries caused by alcohol, 
hepatitis virus, and toxins (Bataller and Brenner, 
2005). The accumulation of the extracellular matrix 
(ECM) including type I collagen is the main patho-
logical alteration in hepatic fibrosis. The terminal 
outcome of liver fibrosis is liver cirrhosis accom-
panied by portal hypertension, hepatic failure and 
hepatocellular carcinoma. 
    Hepatic stellate cells (HSCs) are the main fibros-
ing cell type in the liver. Quiescent HSCs are desmin- 
positive, perisinusoidal cells that are the primary 
sites of vitamin A storage in our bodies. Upon fibro-
genic stimuli, quiescent HSCs transform into activated 
myofibroblasts, which produce ECMs such as type 
I collagen (Bataller and Brenner, 2005). Activated 
HSCs also produce proinflammatory cytokines and 
chemokines, which recruit HSCs and inflammatory 
cells to the site of liver injury. Until now there has 
been no effective antifibrotic therapy available, and 
many investigators have been trying to develop an 
antifibrotic agent that targets fibrogenic responses 
in HSCs. 
    It has been demonstrated that reactive oxygen 
species (ROS) play an important role in hepatic 
fibrogenesis from various liver injuries including 
alcohol abuse, hepatitis C virus infection, iron over-
load and chronic cholestasis (Poli and Parola, 
1997; Pietrangelo, 1998; Parola and Robino, 2001). 
ROS is directly fibrogenic because it induces the 
activation of the collagen type I gene in HSCs 
(Nieto et al., 2000). ROS also stimulates prolifera-
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Figure 1. The chemical structure of magnesium lithospermate B.
Group AST (IU/L) ALT (IU/L)
Control 112.5± 24.9   46.8± 4.9
Control + LAB 114.5± 16.5   50.5± 6.2
TAA 8-week 280.5± 119.9† 100.0± 17.9†
TAA + LAB 8-week 114.0± 12.2*   71.5± 9.3*
TAA 12-week 232.5± 46.8†   79.0± 10.1†
TAA + LAB 12-week 245.8± 76.4   92.5± 21.3
†P＜ 0.05 compared with Control.  *P＜ 0.05 compared with TAA 
8-week.
Table 1. Serum aminotransferase levels 
Figure 2. MLB suppresses hepatic fibrosis in TAA-treated rats. The ex-
tent of hepatic fibrosis was assessed by Masson's trichrome staining (A, 
B, C, and D, original magnification× 40); (A)  TAA 8-week, (B) TAA 
8-week + MLB, (C) TAA 12-week, (D) TAA 12-week + MLB. (E) 
Masson’s trichrome-stained area was quantified using a computerized 
imaging analysis system. (F) Hepatic hydroxyproline content was colori-
metrically quantified from liver samples. *P＜ 0.05 compared with TAA 
8-week, **P＜ 0.01 compared with TAA 8-week, †P＜ 0.01 compared 
with TAA 12-week.
tion and invasiveness of HSCs (Galli et al., 2005). 
Activation of MAPK pathways and NF-κB signaling 
cascades has been implicated in liver injury from 
oxidative stress (Czaja, 2007; Eng and Friedman, 
2001). Free radicals or lipid peroxidation products 
stimulate the activation of HSCs through induction 
of c-myb and NF-κB, which is blocked by antioxi-
dants such as α-tocopherol (Lee et al., 1995). 
    Salvia miltiorrhizae, also known as ‘Danshen,’ is 
a traditional herbal medicine that has been widely 
used for the treatment of vascular diseases in China 
(Zhou et al., 2005). It has been reported that 
Danshen contains multiple chemical constituents 
including lipophilic and hydrophilic compounds. 
Polyphenolic acids are the major type of hydro-
philic components of Danshen. Magnesium lithos-
permate B (MLB) is one of the major active poly-
phenolic acids from Salvia miltiorrhizae (Zhou et 
al., 2005) (Figure 1). It was reported that admini-
stration of water-soluble extract of Salvia miltiorrhizae 
reduces hepatic fibrosis caused by carbon tetra-
chloride (CCl4) administration or bile duct ligation 
(BDL) (Wasser et al., 1998; Nan et al., 2001; Lee 
et al., 2003). However, it is still unknown which 
hydrophilic component of Salvia miltiorrhizae exerts 
an antifibrotic effect in the liver. In this study we 
investigated the effects of purified magnesium lithos-
permate B (MLB) on thioacetamide (TAA)-induced 
hepatic fibrosis in rats and on the fibrogenic res-
ponses in HSCs. 
Results
MLB attenuates TAA-induced liver injury and hepatic 
fibrosis in rats
The extent of liver injury was assessed by measur-
ing serum aminotransferase levels (Table 1). Eight 
or 12 weeks of TAA treatment induced significant 
elevation of AST and ALT levels as compared to 
the control group (P＜ 0.05). The levels of AST 
and ALT were significantly lower in the TAA + LAB 
8-week group than in the TAA 8-week group (P＜
0.05). However, MLB failed to decrease AST or 
ALT levels in 12 weeks of TAA treatment. 
    The extent of hepatic fibrosis was analyzed by 
morphometric quantitation of Masson's trichrome 
stained area in liver sections. The representative 
photomicrographs are shown in Figure 1. Fibrous 
septa developed in rats treated with TAA for 8 
weeks. These septa incompletely surrounded the 
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Figure 3. MLB inhibits HSC activation in TAA-treated rats. Activation of 
HSCs was assessed by α-SMA staining (A, B, C, and D, original magnifi-
cation× 40); (A) TAA 8-week, (B) TAA 8-week + MLB, (C) TAA 
12-week, (D) TAA 12-week + MLB. (E) The α-SMA-stained area was 
quantitated using a computerized imaging analysis system. *P＜ 0.05 
compared with TAA 8-week, **P＜ 0.05 compared with TAA-12 week.
Figure 4. Hepatic mRNA expression of fibrosis-related genes in 
TAA-treated rats. (A) α-SMA, (B) TGF-β1, (C) collagen α1(I) mRNA lev-
els in rat livers were quantified by quantitative RT-PCR using Taqman 
probe after reverse transcription. The mRNA expression of these mole-
cules was normalized with rat PBGD expression. Data represent the 
mean± SD of two independent experiments. †P＜ 0.01 compared 
with TAA-8 week, *P＜ 0.01 compared with TAA-12 week, **P＜ 0.05 
compared with TAA 12-week.
regenerative parenchyma and a partial nodular 
formation was present without development of 
obvious cirrhosis (Figure 2A). The septal fibrosis 
presented in the TAA 8-week group was attenuated 
by MLB (Figure 2B). After 12 weeks of TAA treat-
ment, multiple cirrhotic nodules of varying size with 
fibrous septa were noted (Figure 2C), and these 
overt cirrhotic changes were also attenuated by 
MLB (Figures 2D). The morphometric measure-
ment of Masson Trichrome stained area using a 
computerized imaging analysis system demonstrated 
that hepatic fibrosis was significantly attenuated by 
MLB in both the 8-week and 12-week TAA treat-
ment groups (P＜ 0.05, P＜ 0.01, respectively) 
(Figure 2E). Treatment with MLB significantly de-
creased the amount of hepatic hydroxyproline 
content in both the 8-week and 12-week TAA treat-
ment groups (P＜ 0.01, P＜ 0.01, respectively) 
(Figure 2F). 
MLB decreases activation of HSCs in TAA-treated 
rats
Activation of HSCs was assessed by measuring 
the α-SMA stained area in the liver. Immuno-
histochemistry showed that α-SMA positive cells 
were evident on the periphery of regenerating 
nodules in rats treated with TAA for both 8 and 12 
weeks (Figures 3A and 3C). Expression of α-SMA 
was decreased in rats treated with TAA + MLB 
(Figures 3B and 3D). The morphometric measurement 
of the α-SMA stained area demonstrated that acti-
vation of HSCs was significantly decreased by 
MLB in both the 8-week and 12-week TAA treat-
ment groups (P＜0.05, P＜0.05, respectively) (Figure 
3E).   
MLB decreases the hepatic fibrogenic responses in 
TAA-treated rats 
We next evaluated the hepatic expression of 
fibrosis-related genes in TAA-treated rats. Treat-
ment with TAA increased hepatic expression of 
fibrosis-related genes including α-SMA, TGF-β1, 
and collagen α1(I). The expression of these 
fibrosis-related genes was significantly decreased 
by MLB in both the 8-week and 12-week TAA treat-
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Figure 5. Effects of MLB on HSCs viability and proliferation. (A) 
Cytotoxicity by MLB was tested in HSCs. HSCs were treated with various 
concentrations (0-300 μM) of MLB for up to 72 h in a serum-free 
condition. Cytotoxicity was assessed by MTT assay. Data represent the 
mean± SD of two independent experiments. (B) Effect of MLB on cell 
proliferation was tested in HSCs. HSCs were stimulated with PDGF (20 
ng/ml) for 24 h with various concentrations (0-100 μM). Data represent 
the mean± SD of two independent experiments. †P＜ 0.01 between 
no treatment and PDGF only, *P＜ 0.05 compared with PDGF only. 
Figure 6. MLB attenuates NF-κB transcriptional activation and in-
flammatory chemokine MCP-1 production in HSCs. (A) HSCs were in-
fected with the Ad5NF-κBLuc (MOI 500) for 12 h in DMEM containing 
0.5% FBS. At 20 h post-infection, HSCs were treated with TNF-α (10 
ng/ml) for 8 h with pretreatment of various concentrations of MLB (0-100 
μM) for 1 h. Cells were lysed and NF-κB-mediated luciferase activity 
was quantified. Data represent the mean± SD of 2 independent experi-
ments and are expressed as fold-increase over unstimulated cells. All 
measurements of luciferase activity were normalized to the protein 
concentration. †P＜ 0.01 between no treatment and TNF-α only, ‡P
＜ 0.01 compared with TNF-α alone. (B) Secreted MCP-1 in culture me-
dium was quantified by ELISA. After 48 h serum starvation, HSCs were 
cultured in medium with 1% FBS for 24 h with various concentrations of 
MLB (0-100 μM). Data represent the mean± SD of two independent 
experiments. *P＜ 0.05 compared with no MLB treatment, **P＜ 0.01 
compared with no MLB treatment. 
ment groups (Figures 4A-C). 
MLB suppresses cell proliferation of HSCs
To investigate the underlying mechanism of the 
antifibrotic effects of MLB, we performed in vitro 
studies using immortalized human HSCs, the main 
fibrogenic cell type in the liver. First, we examined 
the cytotoxicity of MLB in cultured HSCs. Incu-
bation of HSCs with MLB (≤100 μM) for up to 48 h 
did not show any discernable cytotoxicity. The 
estimated cell viability as assessed by MTT assay 
after 72 h of treatment with 50 μM MLB was 93.4% 
± 4.1% (Figure 5A). We then assessed the effect 
of MLB on HSC proliferation. Cell proliferation 
measured by MTT assay after 24 hours is shown 
in Figure 5B. The cell number of HSCs increased 
significantly after PDGF stimulation (P＜ 0.01). 
PDGF-induced HSC proliferation was significantly 
suppressed by pretreatment with MLB in a dose- 
dependent manner (P＜ 0.05). 
MLB suppresses NF-κB activation and MCP-1 
production in HSCs 
We next examined whether MLB has an anti- 
inflammatory effect on HSCs. NF-κB transcriptional 
activation was assessed using an NF-κB-dependent 
luciferase assay and monocyte chemotactic pro-
tein-1 (MCP-1) from the culture supernatant was 
measured using an ELISA assay. As shown in 
Figures 6A and 6B, MLB inhibited NF-κB activation 
and MCP-1 production in HSCs in a dose-dependent 
manner, indicating that MLB has an anti-inflamma-
tory effect on HSCs. 
MLB inhibits ROS generation and type I collagen 
secretion in HSCs 
It has been reported that ROS generation stimu-
lates type I collagen production in HSCs. We con-
tinuously measured intracellular ROS formation in 
HSCs using a fluorometer after loading cells with 
the redox-sensitive dye CM-H2DCFDA. As shown 
in Figure 7A, 100 μM of H2O2 markedly induced 
ROS production in HSCs. However, HSCs pre- 
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Figure 7. MLB causes decreases in ROS production and type I collagen secretion in 
HSCs. (A) Serum starved HSCs were pre-incubated with various concentrations of MLB 
(0-100 μM). After loading redox-sensitive dye CM-H2DCFDA (10 μM) into HSCs, cells 
were stimulated with 100 μM H2O2 and fluorescence was measured with a 
spectrometer. (B) HSCs were treated with various concentrations of MLB (0-100 μM) for 
48 h. Western blot of the precipitated proteins from the culture supernatant probed for 
type I collagen; Western blot of cellular proteins (20 μg/ml) probed for α-SMA or 
α-tubulin.  
incubated with MLB (≥50 μM) showed markedly 
reduced ROS production after stimulation with 
H2O2. Finally, we measured the secreted type I 
collagen from HSCs in the culture supernatant. 
Secretion of type I collagen was inhibited by treat-
ment with MLB (≥50 μM) (Figure 7B). However, 
the expression of α-SMA was not affected by 
treatment with MLB. 
Discussion
Several investigators reported that water-soluble 
crude extracts of Salvia miltiorrhizae reduced hepatic 
fibrosis caused by CCl4 administration and BDL in 
rats (Wasser et al., 1998; Nan et al., 2001; Lee et 
al., 2003). Water-soluble components extracted 
from Salvia miltiorrhizae contain at least six phenolic 
constituents including MLB, rosmarinic acid (RA), 
lithospermic acid (LA), caffeic acid (CAA), proto-
catechuic aldehyde (PAL), and 3,4-dihydroxyphe-
nyllactic acid (danshensu) (Li et al., 2005). How-
ever, it is still unknown which hydrophilic compo-
nent of Salvia miltiorrhizae exerts antifibrotic effects 
in the liver. In this study, we demonstrated that purified 
MLB has an anti-fibrotic effect on TAA-induced 
hepatic fibrosis in rats. We also demonstrated that 
purified MLB inhibits the proliferation, chemokine 
production, ROS production and type I collagen 
secretion of HSCs, a main fibrogenic cell type in 
the liver. Our data indicates that MLB is an active 
anti-fibrogenic component of Salvia miltiorrhizae 
and exerts an antifibrotic effect through the sup-
pression of proinflammatory and fibrogenic res-
ponses in HSCs. 
    In this study we investigated the effects of 
purified MLB on TAA-induced hepatic fibrosis in 
rats. TAA is a potent hepatotoxin. It is transformed 
into TAA sulfoxide or TAA sulfone by cytochrome 
P450 and induces oxidative damage to the liver 
(Wasser and Tan, 1999). When compared to CCl4- 
induced hepatic fibrosis, TAA-induced hepatic 
fibrosis in rodents shows more prominent regene-
rating of cirrhotic nodules and is histologically more 
similar to human liver cirrhosis. In our in vivo study, 
the rats were sacrificed after 8 or 12 weeks of TAA 
treatment. The condition of the rats treated with 
TAA for 8 weeks corresponded to the early stages 
of liver cirrhosis, and that of the rats treated for 12 
weeks corresponded to overt liver cirrhosis. We 
used 40 mg/kg/d of MLB for the in vivo experiment, 
because 25 mg/kg/d crude extract of Salvia miltiorrhizae 
had a modest hepatoprotective effect and 50 mg/ 
kg/d of Salvia miltiorrhizae  showed a significant 
hepatoprotective effect in a CCl4-treated liver (Lee 
et al., 2003). Oral administration of MLB significantly 
attenuated liver fibrosis and activation of HSCs in 
both the early and late stages of liver cirrhosis in 
rats. Interestingly, MLB attenuated the extent of 
TAA-induced liver injury only in 8-week treated 
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rats, but not in 12-week treated rats. Taken together, 
these results suggest that MLB has a direct anti- 
fibrogenic effect and has a modest hepato-pro-
tective effect as well. 
    Based on the in vivo results, we investigated the 
underlying mechanism of the anti-fibrotic effect of 
MLB in HSCs, a main fibrogenic cell type in the 
liver. It was reported that Salvia miltiorrhizae attenuates 
TGF-β1-induced mRNA upregulation of fibrosis 
related genes, including α-SMA, connective tissue 
growth factor (CTGF), and TIMP-1 in rat HSCs 
(Hsu et al., 2005). HSC activation and proliferation 
is of crucial importance in hepatic fibrogenesis. 
PDGF appears to be the most potent mitogen of 
HSCs during hepatic fibrogenesis (Marra et al., 
1994). Our in vitro experiments demonstrated that 
MLB inhibits PDGF-induced HSC proliferation in a 
dose-dependent manner. Activated HSCs produce 
various kinds of cytokines and chemokines in 
response to liver injuries, resulting in the recruit-
ment of other inflammatory cells and HSCs to the 
injured site (Bataller and Brenner, 2005). NF-κB is 
an important signaling molecule involved in inflam-
matory signaling in HSCs (Paik et al., 2003). Our 
results show that MLB inhibits NF-κB transcrip-
tional activation and suppresses downstream pro-
inflammatory chemokine MCP-1 production in HSCs. 
These anti-proliferative and anti-inflammatory effects 
of MLB on HSCs may contribute at least partially to 
the in vivo anti-fibrotic effects of MLB.
    It has been demonstrated that ROS plays an 
important role in hepatic fibrogenesis from various 
liver injuries including alcohol abuse, hepatitis C 
virus infection, iron overload and chronic cholestasis 
(Poli and Parola, 1997; Pietrangelo, 1998; Parola 
and Robino, 2001). Type I collagen is a main extra-
cellular matrix that is accumulated in cirrhotic liver. 
ROS is directly fibrogenic because it induces 
activation of the collagen type I gene in HSCs 
(Nieto et al., 2000). ROS also stimulates the pro-
liferation and invasiveness of HSCs (Galli et al., 
2005). We demonstrated that MLB suppresses ROS 
production and type I collagen production in HSCs. 
These results indicate that MLB has a potent anti- 
oxidative effect and a direct anti-fibrotic effect on 
HSCs. 
    In this study, we demonstrated the anti-fibrotic 
effect of MLB in TAA-induced hepatic fibrosis in 
rats. Our in vitro data indicate that MLB has anti- 
proliferative, anti-inflammatory, anti-oxidative, and 
anti-fibrotic effects on activated HSCs. Taken toge-
ther, these results suggest that MLB may be used 
as an effective anti-fibrotic agent for the hepatic 
fibrosis. Further clinical trials examining the anti- 
fibrotic effects of MLB in patients with liver cirrhosis 
are warranted.
Methods
Magnesium lithospermate B preparation
MLB was isolated and purified from Salvia miltiorrhizae as 
described previously (Jung et al., 2002). Slices of the dried 
roots of Salviae miltiorrhizae (1.0 kg) were placed in water 
at 100oC for two hours. The heating water extract was 
evaporated to dryness under reduced pressure at 70oC. 
The heating water extract was suspended in water (500 
mL), and the water extract was adjusted to pH 3.5 with 
hydrogen chloride (HCl) and extracted with saturated butyl 
alcohol (300 ml× 5 each). The butyl alcohol extract was 
evaporated to dryness under reduced pressure at 70oC. 
Then, the butyl alcohol extracts were suspended in water 
(300 ml) and the water extracts were washed with hexane 
(300 ml× 3 each). The water extract was evaporated to 
dryness under reduced pressure at 70oC. The water 
extract was extracted with ethyl acetate (300 ml× 3 each). 
The ethyl acetate extract and water extract were eva-
porated to dryness under reduced pressure at 70oC. The 
ethyl acetate extract and the water extract were purified by 
recrystallization and fractional crystallization. The yield of 
the MLB as amorphous powder was 10 g from Salviae 
miltiorrhizae (1.0 kg). All spectral data (NMR, 13C-NMR, 
IR, HR-MS) of MLB were identical to those of literature 
(Yokozawa et al., 1989). The chemical structure of MLB is 
illustrated in Figure 1. 
Animal experiments of hepatic fibrosis
Six-week-old male Sprague-Dawley rats were prepared. 
Hepatic fibrosis was induced by an intraperitoneal injection 
of TAA (Sigma, St. Louis, MO) at a dose of 200 mg/kg 
twice a week for up to 12 weeks. Rats were fed MLB once 
daily for up to 12 weeks at a dose of 40 mg/kg using a 
gavage tube. The rats were randomly assigned to six 
experimental groups: the control group (n = 5), the control
+ MLB group (n = 5), the TAA 8-week group (n = 5), the 
TAA + MLB 8-week group (n = 5), the TAA 12-week group 
(n = 5), and the TAA + MLB 12-week group (n =5). The 
TAA 8-week group and the TAA + LAB 8-week groups were 
sacrificed 8 weeks after the first TAA injection. All of the 
other rats were sacrificed at week 12. At the time of 
sacrifice, blood and liver samples were harvested. The 
livers were fixed in 10% formalin for histological analysis. 
Portions of liver tissue were immediately frozen in liquid 
nitrogen for further RNA and protein analysis. All experi-
mental procedures were performed according to the guide-
lines for the care and use of animals established by Yonsei 
University College of Medicine.
Assessment of hepatic fibrosis 
Four-micrometer-thick sections of formalin-fixed and paraffin- 
embedded livers from all the experimental groups were 
processed for hematoxylin and eosin staining (H&E) and 
Masson's trichrome staining. Tissue sections were immu-
nostained for α-SMA (Dako North America, Inc., Car-
pinteria, CA), diluted at 1:1000. Stained liver sections were 
analyzed with the computerized imaging analysis system 
(MetaMorph version 4.65, Universal Imaging Corp., Down-
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ingtown, PA). Hydroxyproline content was quantified 
colorimetrically from 0.2 g liver samples as previously des-
cribed (Bataller et al., 2003). The results were expressed 
as micrograms of hydroxyproline per grams of liver.
Serum biochemistry 
Rat whole blood was obtained at the time of sacrifice via 
vena cava puncture. After centrifugation of each blood 
sample, the serum was obtained and examined for both 
aspartate aminotransferase (AST) and alanine amino-
transferase (ALT).
RNA isolation and quantitative RT-PCR
Total RNA was extracted from frozen rat liver tissues, using 
Takara RNA PCR (AMV) Ver 3.0 (Takara Bio Inc., Shiga, 
Japan) as described in the product protocol, and cDNA 
was generated from 1 μg of total RNA, using oligo dT- 
Adaptor primers and Avian Myeloblastosis Virus reverse 
transcriptase (Life Science, Boston, MA). α-SMA, TGF-β1, 
collagen α1(I) mRNA in rat liver samples were quantified 
by quantitative RT-PCR using a Taqman probe (Roche, 
Mannheim, Germany) and  LightCyclerⓇ (Roche Diagnostics 
GmbH, Mannheim, Germany). The PCR primers for α- 
SMA were 5'-CGATAGAACACGGCATCATCAC-3' sense 
and 5'-GCATAGCCCTCATAGATAGGCA-3' antisense. The 
PCR primers for TGF-β1 were 5'-CCTGGAAAGGGCTCAA 
CAC-3' sense and 5'-CAGTTCTTCTCTGTGGAGCTGA-3’ 
antisense. The PCR primers for collagen α1(I) were 5'- 
CATGTTCAGCTTTGTGGACCT-3' sense and 5'-GCAGC 
TGACTTCAGGGATGT-3' antisense. The relative expre-
ssion of target gene mRNA was normalized to the amount 
of rat porphobilinogen deaminase (PBGD) mRNA in an 
identical cDNA sample (de Kok et al., 2005). The PCR 
primers for PBGD were 5'-CACCTGGAATTCAAGAGTATTCG-3' 
sense and 5'-CCAGGATAATGGCACTGAACT-3' antisense. 
The relative abundance of the target genes was obtained 
by calculation using the comparative threshold cycle (Ct) 
method.
HSCs culture
We used immortalized human HSCs that were established 
by retroviral expression of human  telomerase reverse 
transcriptase (hTERT) in this study (Schnabl et al., 2002). 
Telomerase-positive HSCs exibit morphological and func-
tional characteristics of activated HSCs. It was proven that 
HSCs with hTERT are very useful in researching the bio-
logy of activated HSCs (Paik et al., 2006, 2009). HSCs 
were cultured in a 5% CO2 humidified incubator at 37oC. 
The cells were grown in Dulbecco's modified Eagle’s 
medium (DMEM) (Invitrogen, Grand Island, NY) containing 
10% fetal bovine serum (FBS) (Invitrogen) and a 1% 
streptomycin-penicillin mixture. 
Cell viability and proliferation assay
Cytotoxicity of MLB in HSCs was assessed using MTT 
assay. HSCs were seeded at a density of 3× 104 cells per 
well in 24-well plates. After 24 h of serum starvation, cells 
were treated with various concentrations of MLB (0-300 
μM). After incubation for up to 72 h, 125 μl of MTT solution 
(2 mg/ml in PBS) was added to each well and incubated 
for 4 h. The supernatant was removed and the cells solu-
bilized in DMSO (250 μl) for 30 min. The optical density at 
540 nm was measured using an enzyme-linked immuno-
sorbent VERSAmaxTM reader (Molecular Devices, Sunny-
vale, CA). For the cell proliferation assay, serum-starved 
HSCs were incubated with PDGF-BB (R&D systems, 
Minneapolis, MN) with MLB (0-100 μM) for 24 h. The 
number of viable cells was measured by MTT assay at a 
wavelength of 540 nm on an ELISA reader.
NF-κB responsive luciferase assay
Recombinant adenoviral vectors expressing a luciferase 
reporter gene driven by NF-κB transcriptional activation 
(Ad5NF-κBLuc) were used for the assessment of NF-κB 
transcriptional activation as described previously (Paik et 
al., 2003). Briefly, HSCs were infected with Ad5NF-κBLuc 
(multiplicity of infection 500) for 12 h in DMEM containing 
0.5% FBS. After infection, the culture medium was 
changed to a fresh medium without FBS, and the culture 
was continued for an additional 8 h. At 20 h post-infection, 
HSCs were stimulated with TNF-α for 8 h in serum-free 
conditions with or without pretreatment with MLB. A 
luciferase assay kit with luciferase cell culture lysis buffer 
(Promega, Madison, WI) was used to measure NF-κB 
mediated transcriptional induction according to the manu-
facturer's protocol. The relative light intensity was mea-
sured by a spectrometer and all measurements of luciferase 
activity were normalized to the protein concentration.
MCP-1 enzyme-linked immunosorbent assay
After 48 h of serum strarvation, HSCs were cultured in 
medium with 1% FBS for 24 h after pretreatment with MLB 
for 1 h. Measurements of secreted MCP-1 in the culture 
supernatant were done by ELISA (R & D Systems, Minne-
apolis, MN).  
Measurement of reactive oxygen species
HSCs were plated at a density of 2× 104 cells/well in a 
96-well plate. After serum starvation for 24 h, cells were 
preincubated with MLB (0, 50, 100 μM) for 1h. After 
washing, cells were loaded with a redox-sensitive dye, 10 
μM of CM-H2DCFDA (Molecular Probes, Eugene, OR) at 
37oC for 30 minutes, and then cells were rinsed twice with 
PBS and stimulated with 100 μM hydrogen peroxide (H2O2). 
CM-H2DCFDA fluorescence was detected at excitation and 
emission wavelengths of 488 nm and 520 nm, respectively. 
ROS formation was measured over a time course of 30 
minutes using a multi-well fluorescence scanner (Fluostar 
Optima, BMG Labtech, Cary, NC).  
Western blot
For detection of collagen I secretion, cells were cultured in 
100 mm culture dishes (106 cells per dish). Cells were 
treated with MLB for 48 h, and 4 ml of cell media were 
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precipitated with 0.76 g of sodium sulfite at 4oC for 3 h and 
centrifuged at 10,000 g for 30 min. Pellets were resus-
pended in 0.5 M acetic acid, and 40 μl aliquots were sub-
jected to electrophoresis on a 7.5% acrylamide gel. After 
blotting, membranes were probed with anti-type I collagen 
antibody (1:1,000; Biodesign International, Saco, MA), 
which recognized the heterotrimer of type I collagen. For 
the detection of cellular α-SMA and α-tubulin, whole-cell 
extracts were prepared using Triton lysis buffer containing 
protease and phosphatase inhibitors. Forty micrograms of 
protein was electrophoresed on 10% sodium dodecyl 
sulfate (SDS) polyacrylamide gels. The gels were blotted 
onto a nitrocellulose membrane. Antibodies against α-SMA 
(Dako) and α-tubulin (Santa Cruz biotechnology), all diluted 
to 1:1000, were used.
Statistics
The data are shown as mean± standard deviation. Data 
were analyzed using the Mann-Whitney U test. Data were 
considered to be statistically significant when P＜ 0.05.
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